In the 18-month trial, people in the early stages of Alzheimer’s who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug.
Larissa was a 21-year-old Canadian college student recovering from COVID-19 when she died from complications related to an accidental overdose of acetaminophen, a medication in probably every drug store and most medicine cabinets in the country.